News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Roberto Iacovelli: The results of CABATEN study presented at GU24
Photo taken from Roberto Iacovelli/X
Jan 29, 2024, 17:38

Roberto Iacovelli: The results of CABATEN study presented at GU24

Roberto Iacovelli, Associate Professor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome, shared on X:
a

“Enrique Grande and Grupo Getne should be commended for their effort in evaluating new treatment options for adrenocortical carcinoma. Below the results of CABATEN study presented at GU24.”

Roberto Iacovelli: The results of CABATEN study presented at GU24
A
ASCOGU24 CABATEN study cancer Enrique Grande OncoDaily Oncology Roberto Iacovelli
Special Coverage
Blog
Mar 31, 2025, 11:49
Sebastian Szmit: The results of the API-CAT study have been published in NEJM
Career
Mar 31, 2025, 11:49
Sanjay Juneja: A tribute to Zachary Keller's threshold of empathy and philosophical legacy
Insight
Mar 31, 2025, 11:46
Runcie C.W. Chidebe: We decided to understand the relationships between attitude to self and health-related quality of life in cancer patients
Blog
Mar 31, 2025, 11:43
Yüksel Ürün: Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Blog
Mar 31, 2025, 11:31
City of Hope - On National Doctors' Day, we celebrate the bold and courageous work of all doctors
Blog
Mar 31, 2025, 11:27
Colorectal Cancer Awareness with Baja - Onco Intelligence
Blog
Mar 31, 2025, 11:24
Nelson Dusetti: Next week I’ll be in Tenerife for the PAMM-EORTC Meeting
Oncolibrary
Mar 31, 2025, 11:22
New Paper Alert: KEYNOTE-921 Trial of Pembrolizumab Plus Docetaxel VS Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer
Blog
Mar 31, 2025, 11:21
Courageous keynote lecture from Benjamin Besse
Blog
Mar 31, 2025, 11:12
Happy National Doctors Day - LUNGevity Foundation
Blog
Mar 31, 2025, 11:03
Marina Puchinskaya: I am deeply honoured to participate in the ELCC 25 Congress
Blog
Mar 31, 2025, 11:02
Alberto Pimentel: Classifying a Cirrhosis Patient with HCC and Multinodular Disease: Barcelona B or C?